These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11334992)

  • 1. Dendritic cell vaccination protects mice against lethality caused by genital herpes simplex virus type 2 infection.
    Schön E; Harandi AM; Nordström I; Holmgren J; Eriksson K
    J Reprod Immunol; 2001 May; 50(2):87-104. PubMed ID: 11334992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
    Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2.
    Zhao X; Deak E; Soderberg K; Linehan M; Spezzano D; Zhu J; Knipe DM; Iwasaki A
    J Exp Med; 2003 Jan; 197(2):153-62. PubMed ID: 12538655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
    Bettahi I; Zhang X; Afifi RE; BenMohamed L
    Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice.
    Harandi AM; Svennerholm B; Holmgren J; Eriksson K
    J Gen Virol; 2001 Apr; 82(Pt 4):845-853. PubMed ID: 11257190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal memory T cells induced by intranasal vaccination are critical for protective T cell recruitment and prevention of genital HSV-2 disease.
    Sato A; Suwanto A; Okabe M; Sato S; Nochi T; Imai T; Koyanagi N; Kunisawa J; Kawaguchi Y; Kiyono H
    J Virol; 2014 Dec; 88(23):13699-708. PubMed ID: 25231301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8
    Lopes PP; Todorov G; Pham TT; Nesburn AB; Bahraoui E; BenMohamed L
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection.
    Önnheim K; Ekblad M; Görander S; Bergström T; Liljeqvist JÅ
    Viruses; 2016 Apr; 8(4):110. PubMed ID: 27110813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoprotein G of herpes simplex virus 2 as a novel vaccine antigen for immunity to genital and neurological disease.
    Görander S; Harandi AM; Lindqvist M; Bergström T; Liljeqvist JÅ
    J Virol; 2012 Jul; 86(14):7544-53. PubMed ID: 22553328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
    Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
    Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
    Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM
    J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
    Tengvall S; O'Hagan D; Harandi AM
    Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immunity to genital herpes simplex [correction of simpex] virus type 2 infection is mediated by T-bet.
    Svensson A; Nordström I; Sun JB; Eriksson K
    J Immunol; 2005 May; 174(10):6266-73. PubMed ID: 15879125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective vaccination against genital herpes simplex virus type 2 (HSV-2) infection in mice is associated with a rapid induction of local IFN-gamma-dependent RANTES production following a vaginal viral challenge.
    Harandi AM; Svennerholm B; Holmgren J; Eriksson K
    Am J Reprod Immunol; 2001 Dec; 46(6):420-4. PubMed ID: 11775012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model.
    Kwant-Mitchell A; Ashkar AA; Rosenthal KL
    J Virol; 2009 Oct; 83(20):10664-76. PubMed ID: 19656896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production.
    Oh JE; Lee MS; Kim YJ; Lee HK
    Sci Rep; 2016 Jan; 6():19089. PubMed ID: 26750802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract.
    Tang VA; Rosenthal KL
    J Reprod Immunol; 2010 Dec; 87(1-2):39-44. PubMed ID: 20688399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract.
    Gallichan WS; Woolstencroft RN; Guarasci T; McCluskie MJ; Davis HL; Rosenthal KL
    J Immunol; 2001 Mar; 166(5):3451-7. PubMed ID: 11207303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
    Milligan GN; Bernstein DI
    Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.